Physiological Pharmaceutics

Colon and rectal drug delivery 179112. Roberts JP, Newell MS, Decks JJ, Waldron DW, Garvie NW, Williams NS. Oral [In-111]DTPA scintigraphic assessment of colonic transit in constipated subjects. Dig. Dis. Sci1993; 38:1032–1039.113. De Boer AG. First-pass elimination of some high clearance drugs following rectaladministration to humans and rats. PhD. Thesis, University of Leiden, The Netherlands.1979.114. De Boer AG, Breimer DD, Pronk FJ, Gubbens-Stibbe JM. Rectal bioavailability oflidocaine in rats: absence of significant first-pass elimination. J. Pharmaceut. Sci. 1980;69:804–807.115. Kleinbloesem CH, van Harten J, de Leede LGJ. Nifedipine kinetics and dynamics duringrectal infusion to steadt state with an osmotic system. Clin. Pharmacol. Therapeut.1984; 36:396–401.116. Manning CD, Vickers AP, Smith G, Graham NB, McNeil ME. The morphine hydrogelsuppository. Br. J. Anaesthesiol. 1988; 61:221–227.117. Tukker J. Biopharmaceutics of fatty suspension suppositories: The influence ofphysiological and physical parameters of spreading and bioavailability in dog and man:PhD thesis, University of Leiden, The Netherlands. 1983.118. Hardy JG, Feely LC, Wood E, Davis SS. The application of gamma-scintigraphy for theevaluation of the relative spreading of suppository bases on rectal hard gelatin capsules.Int. J. Pharmaceut. 1987; 38:103–108.119. Sugito K, Ogata H, Noguchi M, Kogure T, Takano M, Maruyama Y, et al. Thespreading of radiolabelled fatty suppository bases in the human rectum. Int. J.Pharmaceut. 1988; 47:157–162.120. Vanbodegraven AA, Boer RO, Lourens J, Tuynman HARE, Sindram JW. Distributionof mesalazine enemas in active and quiescent ulcerative-colitis. Aliment. Pharmacol.Therapeut. 1996; 10:327–332.121. Wood E, Wilson CG, Hardy JG. The spreading of foam and solution enemas. Int. J.Pharmaceut. 1985; 25:191–197.122. Moolenaar F, Bakker S, Visser J, Huizinga T. Comparative biopharmaceutics ofdiazepam after single rectal, oral, intramuscular and intravenous administration in man.Int. J. Pharmaceut. 1980; 5:127–137.123. Shrirai H, Miura H, Sunaoshi W. A clinical study on the effectiveness of intermittenttherapy with rectal diazepam suppositories for the prevention of recurrent febrileconvulsions and the development of epilepsy during the study period. Brain andDevelopment 1988; 10:201–202.124. Dhillon S, Oxley J, Richens A. Bioavailability of diazepam after intravenous, oral and rectaladministration in adult epileptic patients. Br: J. Clin. Pharmacol. 1982; 13:427–432.125. Milligan N, Dhillon S, Richens A, Oxley J. Absorption of diazepam from the rectumand its effect on interrictal spikes in the EEG. Epilepsia 1982; 23:323–331.126. De Boer AG, Moolenaar F, de Leede LGJ, Breimer DD. Rectal drug administration:clinical pharmacokinetic considerations. Clin. Pharmacokinet. 1982; 7:285–311.127. Graves NM, Kriel RL, Jones-Saete C, Cloyd JC. Relative bioavailability of rectallyadministered carbemazepine suspension in humans. Epilepsia 1985; 26:429–433.128. Neuvonen PJ, Tokoia O. Bioavailability of rectally administered carbamazepinemixture. Br. J. Clin. Pharmacol. 1987; 24:839–841.129. Saint-Maurice C, Meistelman C, Rey E, Esteve C, de Lauture D. The pharmacokineticsof rectal midazolam for premedication in children. Anaesthesiol. 1986; 65:536–538.130. Clausen TG, Wolff J, Hansen PB, Larsen F, Rasmussen SN. Pharmacokinetics ofmidazolam and a-hydroxy-midazolam following rectal and intravenous administration.Br. J. Clin. Pharmacol. 1988; 25:457–463,131. Ravnborg M, Hasselstrøm L, Østengard D. Premedication with oral and rectaldiazepam. Acta Anaesthesiol. Scand. 1986; 30:132–138.132. Lundgren S, Ekman A, Blomback U. Rectal administration of diazepam in solution.Swed. Dent. J. 1979; 2:161–166.133. Kraus G, Frank S, Knoll R, Prestele H. pharmakokinetische Untersuchungen nachintravenoser, intermuskularar und rektaler. Applikation von Methohexital bei Kindern.Anaesthesist 1984; 33:266–271.